Omega Fund Management, LLC Long-Term Concentrated

CIK: 0001637359 · Show all filings

Period: Q4 2019 (← Previous) (Next →)

Filing Date: Feb 13, 2020

Total Value ($000): $314,167 (100.0% shares, 0.0% debt)

Holdings (14)

GOSS Gossamer Bio 30.4%

Value ($000) $95,645 Shares 6,119,345 Est. Cost $20.85 Unrealized -3.4%

REPL Replimune Group 24.2%

Value ($000) $76,142 Shares 5,323,455 Est. Cost $17.40 Unrealized -17.2%

— Morphic Holding 16.2%

Value ($000) $50,958 Shares 2,969,582 Est. Cost $19.82 Unrealized —

— Translate Bio 6.3%

Value ($000) $19,842 Shares 2,437,603 Est. Cost $12.65 Unrealized —

IMUX Immunic 4.2%

Value ($000) $13,303 Shares 1,371,494 Est. Cost $13.14 Unrealized -36.7%

— Prevail Therapeutics 3.4%

Value ($000) $10,589 Shares 668,907 Est. Cost $13.20 Unrealized —

— Paratek Pharmaceuticals 3.3%

Value ($000) $10,480 Shares 2,600,410 Est. Cost $34.18 Unrealized —

— ESSA Pharma 3.0%

Value ($000) $9,404 Shares 1,709,848 Est. Cost $3.14 Unrealized —

— Cidara Therapeutics 2.0%

Value ($000) $6,300 Shares 1,640,514 Est. Cost $6.35 Unrealized —

— FibroGen 1.8%

Value ($000) $5,603 Shares 130,646 Est. Cost $27.34 Unrealized —

TRVI Trevi Therapeutics 1.5%

Value ($000) $4,738 Shares 1,263,408 Est. Cost $8.61 Unrealized -56.5%

— Jounce Therapeutics 1.5%

Value ($000) $4,627 Shares 529,965 Est. Cost $21.99 Unrealized —

— ObsEva 1.2%

Value ($000) $3,818 Shares 999,364 Est. Cost $9.76 Unrealized —

— Pieris Pharmaceuticals 0.9%

Value ($000) $2,718 Shares 750,741 Est. Cost $1.83 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
GOSS	Gossamer Bio	6,119,345	$95,645	30.4%	$20.85	-3.4%	Common Stock	38341P102
REPL	Replimune Group	5,323,455	$76,142	24.2%	$17.40	-17.2%	Common Stock	76029N106
—	Morphic Holding	2,969,582	$50,958	16.2%	$19.82	—	Common Stock	61775R105
—	Translate Bio	2,437,603	$19,842	6.3%	$12.65	—	Common Stock	89374L104
IMUX	Immunic	1,371,494	$13,303	4.2%	$13.14	-36.7%	Common Stock	4525EP101
—	Prevail Therapeutics	668,907	$10,589	3.4%	$13.20	—	Common Stock	74140Y101
—	Paratek Pharmaceuticals	2,600,410	$10,480	3.3%	$34.18	—	Common Stock	699374302
—	ESSA Pharma	1,709,848	$9,404	3.0%	$3.14	—	Common Stock	29668H708
—	Cidara Therapeutics	1,640,514	$6,300	2.0%	$6.35	—	Common Stock	171757107
—	FibroGen	130,646	$5,603	1.8%	$27.34	—	Common Stock	31572Q808
TRVI	Trevi Therapeutics	1,263,408	$4,738	1.5%	$8.61	-56.5%	Common Stock	89532M101
—	Jounce Therapeutics	529,965	$4,627	1.5%	$21.99	—	Common Stock	481116101
—	ObsEva	999,364	$3,818	1.2%	$9.76	—	Common Stock	H5861P103
—	Pieris Pharmaceuticals	750,741	$2,718	0.9%	$1.83	—	Common Stock	720795103